In particular, in a model of glioblastoma, the α-tubulin decrease—due to genetic alteration or pharmacological treatment—induced a downregulation of BNIP3 and NIX, and inhibited the selective mitophagic removal of mitochondria. The gene discussed is BNIP3L; the disease is glioblastoma.